EGFR and colorectal cancer: Systemic treatment for patients with RAS wild type (wt) colorectal cancer (mCRC) includes anti– epidermal growth factor receptor (EGFR) monoclonal antibody (mAb) treatment with either cetuximab or panitumumab as monotherapy or in combination with chemotherapy [1].